Alkermes plc Long-Term Investments

Alkermes plc posts a long-term investments of $35M as of June 2026. That compares with $38M in the prior-year period — down 8.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Alkermes plc's long-term investments was $38M. The latest reading is $35M — a 8.4% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Long-Term Investments is one piece of Alkermes plc's financial statement story. At $35M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ALKS's long-term investments usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Alkermes plc's other metric pages and overview cover the third.

Judging Alkermes plc against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in long-term investments easier to interpret. Start with $35M here, then scan peer and history charts to see if the gap is persistent.